Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 779855
                    [Title] => Novartis, NKTI tie up to help GEP NET patients
                    [Summary] => 
Novartis Oncology has formed an alliance with the National Kidney and Transplant Institute (NKTI) to help improve the diagnosis and management of patients with gastroenteropancreatic neuroendocrine tumors (GEP NETs), a form of cancer frequently difficult to diagnose and treat or manage.
                    [DatePublished] => 2012-02-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 698526
                    [Title] => Novartis partners with NKTI to enhance  mg't of gastrointestinal stromal tumor
                    [Summary] => 
Research-based health care company Novartis has partnered with the National Kidney and Transplant Institute (NKTI) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.
                    [DatePublished] => 2011-06-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

DR. JANUARIO ANTONIO VELOSO

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 779855
                    [Title] => Novartis, NKTI tie up to help GEP NET patients
                    [Summary] => 
Novartis Oncology has formed an alliance with the National Kidney and Transplant Institute (NKTI) to help improve the diagnosis and management of patients with gastroenteropancreatic neuroendocrine tumors (GEP NETs), a form of cancer frequently difficult to diagnose and treat or manage.
                    [DatePublished] => 2012-02-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 698526
                    [Title] => Novartis partners with NKTI to enhance  mg't of gastrointestinal stromal tumor
                    [Summary] => 
Research-based health care company Novartis has partnered with the National Kidney and Transplant Institute (NKTI) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.
                    [DatePublished] => 2011-06-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Novartis, NKTI tie up to help GEP NET patients

February 23, 2012 - 12:00am

Novartis Oncology has formed an alliance with the National Kidney and Transplant Institute (NKTI) to help improve the diagnosis and management of patients with gastroenteropancreatic neuroendocrine tumors (GEP NETs),...

Science and Environment

Novartis partners with NKTI to enhance mg't of gastrointestinal stromal tumor

June 23, 2011 - 12:00am

Research-based health care company Novartis has partnered with the National Kidney and Transplant Institute (NKTI) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.

Science and Environment